Dr. Roger Owen, MD, MRCP, FRCPath, serves as a Consultant in Clinical Haematology and Haematopathology at the St James’s Institute of Oncology, Leeds Teaching Hospitals NHS Trust. His academic and clinical journey began with a medical degree from the University of Wales College of Medicine in 1988, followed by gaining his MRCP from the Royal College of Physicians, London, and his FRCPath from the Royal College of Pathologists, London.
Education and Training
Dr. Roger Owen received his medical degree from the University of Wales College of Medicine in 1988. He then earned his MRCP from the Royal College of Physicians, London, and his FRCPath from the Royal College of Pathologists, London.
Research and Specialisation
Dr. Owen has dedicated a significant portion of his career to the study and treatment of Waldenström’s macroglobulinaemia (WM), myeloma, and related plasma cell disorders. His pioneering work includes the development of a disease-specific assay for WM and leading roles in national and international treatment guidelines for these conditions. With over 100 original papers published in prestigious journals, his contributions to haematology extend beyond patient care to shaping clinical practices and research in WM, myeloma, and plasmacytoma.
Leadership and Clinical Focus
Dr. Owen’s leadership roles include developing national and international treatment guidelines for WM and related conditions. His work has been recognized with the prestigious Waldenström’s Award at the 9th International Workshop on Waldenström’s Macroglobulinaemia in Amsterdam. In addition to his clinical responsibilities, Dr. Owen actively contributes to the advancement of haematology through his involvement in national clinical trial groups and as a member of WMUK’s Clinical Advisory Committee & Research Committee.
Contributions and Impact
As a Consultant Haematologist, Dr. Owen has a particular interest in the diagnosis, treatment, and disease monitoring in patients with Myeloma, MGUS, Waldenström’s macroglobulinaemia, and marginal zone lymphoma. He has published extensively in renowned journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Blood.
Collaborative Initiatives and Services
Dr. Owen has collaborated extensively with various professionals and organizations. Beyond his clinical and research endeavors, he serves as a Trustee of the Friends of Leeds Centre for Leukaemia, Lymphoma, and Myeloma since 2007.
- Works for: St James’s Institute of Oncology, Leeds Teaching Hospitals NHS Trust
- Member of Organisations:
- Occupation: Consultant Haematologist
- Alumni Of: University of Wales College of Medicine (now merged with Cardiff)
- Qualifications: MD, MRCP, FRCPath
- Links:
- Friends of Leeds Centre for Leukaemia, Lymphoma, and Myeloma
- Leeds Teaching Hospitals NHS Trust Profile
- Bupa Consultant Profile
- Facebook Post
- HME Forum Profile (for healthcare professionals only)
